NADPH oxidase and PDA4 inhibitors have been reported to significantly decrease tumor cell invasion, suggesting that NET-mediated tumor cell invasion requires neutrophil NADPH oxidase and PDA4 activity (21). The gene discussed is FMO5; the disease is neoplasm.